Pharmaceutical - Financial, AbbVie

Filter

Current filters:

FinancialAbbVie

Popular Filters

AbbVie issues earnings-per-share guidance up 30% for 2015

AbbVie issues earnings-per-share guidance up 30% for 2015

12-01-2015

US drugmaker AbbVie has issued updated guidance about its expected earnings in 2015.

AbbVieAnti-viralsFinancialHumiraPharmaceuticalUSAViekira Pak

AbbVie, still fuelled by Humira, beats own and analysts’ forecasts

AbbVie, still fuelled by Humira, beats own and analysts’ forecasts

01-11-2014

Just a couple of weeks after abandoning its $54 billion “tax inversion” motivated takeover of Ireland-headquartered…

AbbVieAnti-Arthritics/RheumaticsFinancialHumiraPharmaceuticalShireUSA

Shire posts sharp rises in sales and earnings for third-qtr

Shire posts sharp rises in sales and earnings for third-qtr

24-10-2014

Ireland-headquartered Shire has delivered a strong set of financials for the third-quarter of 2014, validating…

AbbVieAmerican depositary shareFinancialPharmaceuticalShire

Shire to receive $1.635 billion break fee from AbbVie

Shire to receive $1.635 billion break fee from AbbVie

21-10-2014

The board of Ireland-headquartered drugmaker Shire has said there is now no realistic prospect of AbbVie…

AbbVieBusiness FinanceCity Code on Takeovers and MergersFinancialMergers & AcquisitionsMergers and acquisitionsPharmaceuticalShireUSA

AbbVie reconsidering $54.6 billion acquisition of Shire

AbbVie reconsidering $54.6 billion acquisition of Shire

15-10-2014

US drugmaker AbbVie has told Ireland-headquartered Shire of its board of directors' intention to meet…

AbbVieFinancialIrelandMergers & AcquisitionsPharmaceuticalShire

Shire to pay $56.5 million in final agreement with US government

Shire to pay $56.5 million in final agreement with US government

25-09-2014

The US subsidiary of Ireland-headquartered Shire will pay $56.5 million to resolve civil allegations…

AbbVieAdderallFinancialLegalPharmaceuticalShireUSAVyvanse

AbbVie 2nd-qtr 2014 earnings beat forecasts

25-07-2014

US drugmaker AbbVie, which has just clinched a $55 billion deal to acquire Ireland-based Shire, reported…

AbbVieFinancialHumiraPharmaceutical

Shire’s strong 2nd-qtr financials justify holding out for higher AbbVie bid

Shire’s strong 2nd-qtr financials justify holding out for higher AbbVie bid

18-07-2014

Ireland-headquartered drugmaker Shire, which has just accepted an increased $54 billion bid from the…

AbbVieFinancialIrelandPharmaceuticalShire

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

14-07-2014

Ireland-headquartered Shire, which just on Friday confirmed it had finally entered talks with suitor…

AbbVieAdalimumabFinancialIrelandMergers & AcquisitionsPharmaceuticalShireUSA

AbbVie justifies its position regarding Shire offer

AbbVie justifies its position regarding Shire offer

26-06-2014

US drugmaker AbbVie has set out its ‘strategic rationale’ for its proposal to buy Ireland headquartered…

AbbVieFinancialPharmaceuticalShire PharmaceuticalsUSA

AbbVie raises expectations driven by strong performance

AbbVie raises expectations driven by strong performance

24-06-2014

US drugmaker AbbVie has raised the midpoint of its full-year 2014 earnings-per-share guidance by six…

AbbVieAmortizationBusiness FinanceFinanceFinancialGuidancePharmaceuticalUSAUSD

AbbVie opens expanded manufacturing facility in Ireland

AbbVie opens expanded manufacturing facility in Ireland

03-06-2014

The chairman and chief of US drugmaker AbbVie, Richard Gonzalez, accompanied by other senior executives,…

AbbVieAnti-viralsFinancialIrelandPharmaceuticalProduction

AbbVie beats forecasts, as Humira sales keep soaring

25-04-2014

US drugmaker AbbVie, now in its second year as an independent spin-out for Abbott, pleased investors…

AbbVieFinancialPharmaceutical

AbbVie files NDA for oral, interferon-free treatment of hepatitis C

22-04-2014

US drugmaker AbbVie has submitted its New Drug Application to the US Food and Drug Administration for…

AbbVieAnti-viralsEnanta PharmaceuticalsFinancialNorth AmericaPharmaceuticalRegulationUSA

AbbVie sees profits downturn but meets analysts’ expectations

AbbVie sees profits downturn but meets analysts’ expectations

01-02-2014

US drugmaker AbbVie’s shares gained 3% to $49.77 in morning trading on January 31, when the company…

AbbVieFinancialPharmaceutical

Morningstar analysts find GlaxoSmithKline has strongest pipeline

Morningstar analysts find GlaxoSmithKline has strongest pipeline

06-11-2013

Morningstar, an independent Chicago-based investment research firm, recently published the November 2013…

AbbVieAstraZenecaBayerFinancialGlaxoSmithKlineMerck & CoPharmaceuticalResearchSanofi

Accelerated growth for AbbVie’s Humira lifts 3rd-quarter results above expectation

Accelerated growth for AbbVie’s Humira lifts 3rd-quarter results above expectation

27-10-2013

Shares of AbbVie were up 2.4% at $49.09 in afternoon trading on the New York Stock Exchange on Friday,…

AbbVieFinancialHumiraPharmaceutical

Yaroslavl region of Russia to become major center for the country’s pharmaceutical production

Yaroslavl region of Russia to become major center for the country’s pharmaceutical production

05-10-2013

The Russian Yaroslavl region is expected to become one of the major centers of the country’s pharmaceutical…

AbbVieCadila PharmaceuticalsEuropeFinancialPharmaceuticalProductionTakeda PharmaceuticalsTeva Pharmaceutical Industries

AbbVie beats expectations, as Humira keeps growing

28-07-2013

US drugmaker AbbVie (NYSE: ABBV), spun-out from Abbott Laboratories from the start of this year, reported…

AbbVieFinancialHumiraPharmaceutical

Abbott sales rise 2.5% in 2nd quarter, but profits plunge

17-07-2013

US health care company Abbott Laboratories (NYSE: ABT), which split out its research-based prescription…

AbbVieFinancialNorth AmericaPharmaceutical

Strong 1st-qtr for AbbVie, as Humira continues to grow

28-04-2013

Shares in US drugmaker AbbVie (NYSE: ABBV) rose 3.6% to $45.84 on Friday, when the company posted first-quarter…

AbbVieFinancialPharmaceutical

AbbVie inaugural full-year outlook for 2013 in line with expectations

31-01-2013

Newly spun-out from Abbott Labs, research-based pharma company AbbVie (NYSE: ABB) yesterday confirmed…

Abbott LaboratoriesAbbVieFinancialPharmaceuticalResearch

Abbott board prepares way for AbbVie split off

29-11-2012

US health care giant Abbott Laboratories (NYSE: ABT) says that its board of directors has approved the…

Abbott LaboratoriesAbbVieFinancialPharmaceutical

Abbott Labs' AbbVie bond deal hit $37 billion yesterday, sources report

06-11-2012

US health care major Abbott Laboratories (NYSE: ABT) and its subsidiary AbbVie came to market early Monday…

Abbott LaboratoriesAbbVieFinancialPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top